{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T15:25:32Z","timestamp":1773847532360,"version":"3.50.1"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:p>High-grade serous ovarian carcinoma (HGOC) is frequently diagnosed at an advanced stage, leading to high recurrence rates. This case report highlights the utility of [<jats:sup>68<\/jats:sup>Ga]Ga-FAPI-46 PET\/MRI in detecting previously unidentified lymph node metastases in a 75-year-old woman with recurrent HGOC, which altered the treatment strategy. The imaging revealed increased [<jats:sup>68<\/jats:sup>Ga]Ga-FAPI-46 uptake in nonenlarged mediastinal and left perihilar lymph nodes, reclassifying the patient from FIGO IIIb to FIGO stage IV and prompting a change in therapeutic management.<\/jats:p>","DOI":"10.1097\/rlu.0000000000005871","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T15:00:23Z","timestamp":1743606023000},"page":"873-874","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["[68Ga]Ga-FAPI-46 PET\/MRT Unveils Lymph Node Metastases and Changes Treatment Strategy in Recurrent Advanced High-grade Serous Ovarian Carcinoma Patient"],"prefix":"10.1097","volume":"50","author":[{"given":"Marie","family":"Prochiner","sequence":"first","affiliation":[{"name":"Department of Clinical Radiology and Nuclear Medicine, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Hinterberger","sequence":"additional","affiliation":[{"name":"DKFZ Hector Cancer Institute at the University Medical Center Mannheim, Heidelberg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f6rn","family":"W\u00e4ngler","sequence":"additional","affiliation":[{"name":"Molecular Imaging and Radiochemistry, Clinic of Radiology and Nuclear Medicine, Medical Faculty Mannheim of Heidelberg University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederik","family":"Marm\u00e9","sequence":"additional","affiliation":[{"name":"Department Obstetrics and Gynecology, University Hospital Mannheim, Mannheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Freba","family":"Grawe","sequence":"additional","affiliation":[{"name":"Department of Clinical Radiology and Nuclear Medicine, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim"},{"name":"DKFZ Hector Cancer Institute at the University Medical Center Mannheim, Heidelberg"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"key":"R1-20250731","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian cancer development and metastasis","volume":"177","author":"Lengyel","year":"2010","journal-title":"Am J Pathol"},{"key":"R2-20250731","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1007\/s00259-023-06369-z","article-title":"[68Ga]Ga-FAPI-04 PET\/CT in the evaluation of epithelial ovarian cancer: comparison with [18F]F-FDG PET\/CT","volume":"50","author":"Chen","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R3-20250731","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13550-020-00712-3","article-title":"Diagnostic value of [18F]FDG PET\/MRI for staging in patients with ovarian cancer","volume":"10","author":"Tsuyoshi","year":"2020","journal-title":"EJNMMI Res"},{"key":"R4-20250731","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1007\/s00259-021-05378-0","article-title":"68Ga-FAPI-PET\/CT in patients with various gynecological malignancies","volume":"48","author":"Dendl","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R5-20250731","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1097\/RLU.0000000000005586","article-title":"Ovarian clear cell adenocarcinoma with low 68 Ga-FAPI-46 and low 18 F-FDG uptake on PET\/CT: a case report","volume":"50","author":"Bentestuen","year":"2025","journal-title":"Clin Nucl Med"},{"key":"R6-20250731","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1097\/RLU.0000000000005537","article-title":"Predicting malignancy in adnexal tumors with FAPI PET\/CT and FDG PET\/CT: a case report on a borderline ovarian tumor","volume":"50","author":"Umachanger","year":"2025","journal-title":"Clin Nucl Med"},{"key":"R7-20250731","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/RLU.0000000000004656","article-title":"68Ga-FAPI-04 PET\/MR versus 18F-FDG PET\/CT in the detection of ovarian cancer","volume":"48","author":"Sun","year":"2023","journal-title":"Clin Nucl Med"},{"key":"R8-20250731","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2967\/jnumed.119.227967","article-title":"68Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer","volume":"60","author":"Kratochwil","year":"2019","journal-title":"J Nucl Med"},{"key":"R9-20250731","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1007\/s00259-023-06235-y","article-title":"A comparative study of [68Ga]Ga-FAPI-04 PET\/MR and [18F]FDG PET\/CT in the diagnostic accuracy and resectability prediction of ovarian cancer","volume":"50","author":"Xi","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R10-20250731","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.2967\/jnumed.118.210435","article-title":"A tumor-imaging method targeting cancer-associated fibroblasts","volume":"59","author":"Loktev","year":"2018","journal-title":"J Nucl Med"},{"key":"R11-20250731","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2967\/jnumed.118.215913","article-title":"68Ga-FAPI PET\/CT: biodistribution and preliminary dosimetry estimate of 2 DOTA-containing FAP-targeting agents in patients with various cancers","volume":"60","author":"Giesel","year":"2019","journal-title":"J Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005871","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T05:00:25Z","timestamp":1753938025000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":11,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005871","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]},"assertion":[{"value":"2024-12-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}